Kala Bio Inc (KALA)
6.75
-0.03
(-0.43%)
USD |
NASDAQ |
Nov 05, 16:00
6.75
0.00 (0.00%)
After-Hours: 16:00
Kala Bio Total Assets (Quarterly): 61.61M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 61.61M |
| March 31, 2024 | 53.03M |
| December 31, 2023 | 55.95M |
| September 30, 2023 | 61.12M |
| June 30, 2023 | 66.50M |
| March 31, 2023 | 72.23M |
| December 31, 2022 | 86.82M |
| September 30, 2022 | 85.70M |
| June 30, 2022 | 84.98M |
| March 31, 2022 | 111.57M |
| December 31, 2021 | 139.43M |
| September 30, 2021 | 193.81M |
| June 30, 2021 | 215.46M |
| March 31, 2021 | 229.83M |
| December 31, 2020 | 221.61M |
| September 30, 2020 | 225.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 245.51M |
| March 31, 2020 | 258.53M |
| December 31, 2019 | 154.32M |
| September 30, 2019 | 161.01M |
| June 30, 2019 | 178.82M |
| March 31, 2019 | 197.02M |
| December 31, 2018 | 220.97M |
| September 30, 2018 | 84.08M |
| June 30, 2018 | 95.59M |
| March 31, 2018 | 104.99M |
| December 31, 2017 | 116.55M |
| September 30, 2017 | 123.69M |
| June 30, 2017 | 28.59M |
| March 31, 2017 | 37.61M |
| December 31, 2016 | 46.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
53.03M
Minimum
Mar 2024
258.53M
Maximum
Mar 2020
138.06M
Average
111.57M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.89M |
| Shareholders Equity (Quarterly) | 13.72M |